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Background: Understanding the regulation of mineral homeostasis and function of the skeleton as buffer for Calcium
and Phosphate has regained new interest with introduction of the syndrome “Chronic Kidney Disease-Mineral and
Bone Disorder”(CKD-MBD). The very rapid minute-to-minute regulation of plasma-Ca2+ (p-Ca2+) takes place via an
exchange mechanism of Ca2+ between plasma and bone. A labile Ca storage pool exists on bone surfaces storing
excess or supplying Ca when blood Ca is lowered. Aim was to examine minute-to-minute regulation of p-Ca2+ in the
very early phase of acute uremia, as induced by total bilateral nephrectomy and to study the effect of absence of
kidneys on the rapid recovery of p-Ca2+ from a brief induction of acute hypocalcemia.
Methods: The rapid regulation of p-Ca2+ was examined in sham-operated rats, acute nephrectomized rats(NX), acute
thyroparathyrectomized(TPTX) rats and NX-TPTX rats.
Results: The results clearly showed that p-Ca2+ falls rapidly and significantly very early after acute NX, from 1.23 ± 0.02 to
1.06 ± 0.04 mM (p < 0.001). Further hypocalcemia was induced by a 30 min iv infusion of EGTA. Control groups had saline.
After discontinuing EGTA a rapid increase in p-Ca2+ took place, but with a lower level in NX rats (p < 0.05). NX-TPTX model
excluded potential effect of accumulation of Calcitonin and C-terminal PTH, both having potential hypocalcemic actions.
Acute TPTX resulted in hypercalcemia, 1.44 ± 0.02 mM and less in NX-TPTX rats,1.41 ± 0.02 mM (p < 0.05). Recovery of
p-Ca2+ from hypocalcemia resulted in lower levels in NX-TPTX than in TPTX rats, 1.20 ± 0.02 vs.1.30 ± 0.02 (p < 0.05)
demonstrating that absence of kidneys significantly affected the rapid regulation of p-Ca2+ independent of PTH, C-PTH
and CT.
Conclusions: P-Ca2+ on a minute-to-minute basis is influenced by presence of kidneys. Hypocalcemia developed
rapidly in acute uremia. Levels of p-Ca2+, obtained during recovery from hypocalcemia resulted in lower levels in
acutely nephrectomized rats. This indicates that kidneys are of significant importance for the ‘set-point’ of p-Ca2+
on bone surface, independently of PTH and calcitonin. Our results point toward existence of an as yet unknown
factor/mechanism, which mediates the axis between kidney and bone, and which is involved in the very rapid
regulation of p-Ca2+.
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Calcium (Ca) has important extracellular as well as
intracellular functions. Its extracellular functions include
its role in blood clotting, maintenance of plasma mem-
brane integrity and intercellular adhesion. Extracellular
Ca provides a source of calcium ions (Ca2+) essential for
intracellular processes. Furthermore, extracellular Ca2+* Correspondence: Ewa.Lewin@regionh.dk
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unless otherwise stated.participates in its own regulation through systemic and
local Ca2+ sensing receptor (CaR) mediated actions in
tissues related to the mineral ion homeostasis [1,2]. Fi-
nally, extracellular Ca provides a constant supply to the
exchange of Ca within the large reservoir of Ca - the
skeleton. The skeleton represents the largest compart-
ment of total body Ca, containing more than 99%.
The free plasma Ca2+ concentration is in normal mam-
mals kept within a very narrow range in the circulating
blood, except for small diurnal variations [2-5]. The detailed
regulation of plasma Ca2+ on the minute-to-minute basistral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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homeostasis is regulated through a complex interplay be-
tween different calciotropic hormones, where deviations in
plasma Ca2+ concentration are sensed by CaR [2]. The CaR
then regulates plasma Ca2+ concentration through direct or
indirect actions on the calcium translocating tissues, bone,
intestine and kidney and via regulation of PTH, calcitriol,
and calcitonin (CT) [2].
The traditional understanding of the Ca homeostasis
provides the following mechanism for the subsequent
normalization of plasma Ca2+ after a brief induction of
hypocalcemia [6-8]. Even a slight reduction in the extra-
cellular Ca2+ concentration elicits a prompt increase in
the rate of PTH secretion. The renal responses to the in-
creased plasma PTH level are phosphaturia, enhanced dis-
tal tubular reabsorption of Ca2+ and increased generation
of the active metabolite of vitamin D, 1,25(OH)2D (calci-
triol), from 25(OH)D by stimulation of the 1α-hydroxylase
in the proximal convoluted tubules. The increased level of
calcitriol stimulates the intestinal absorption of phosphate
(P) and Ca. PTH and calcitriol promote net release of P
and Ca from bone. The increased flux of Ca2+ into the
extracellular fluid, coupled with renal retention of Ca2+ re-
store circulating Ca2+ levels toward normal, and thereby
inhibits PTH secretion and close the negative feedback
loop. In this model of Ca2+ homeostasis the emphasis is
on the key role of PTH and kidney. This classical model
of plasma Ca2+ regulation does indeed apply to the long-
term regulation and stability of plasma Ca2+, but does not
apply to the very rapid minute-to-minute regulation of
plasma Ca2+, as previously clearly shown from our lab.
[9-12].
The conceptual framework on how plasma Ca2+ is
held constant has been expanded by Kurokawa [13],
who described an elegant concept, which combined the
set point for the Ca2+ flux between extracellular fluid
volume (ECF) and bone, and the set point for renal
tubular Ca2+ reabsorption in relation to the set point for
the Ca2+ regulated PTH secretion from the parathyroids
[13]. The interplay between PTH and calcitriol will ef-
fectively set the Ca2+ level in ECF by adjusting the set
points in the different organs to the same level of Ca2+.
As such the set points of the Ca2+ regulating tissues
correspond to the resulting plasma Ca2+ level, which
the organism is maintaining. This elegant concept is
strongly supported by results from studies on the regu-
lation of renal tubular reabsorption of Ca2+ [7,14,15].
The site along the nephron where the set point for cal-
cium reabsorption is present and regulated appears to
be in the distal nephron segments, where the PTH/
PTHrP receptor (PTH1R) and the vitamin D receptor
(VDR) are located [16-18] together with the vitamin D
inducible calcium-binding protein, calbindin-D28K,
Klotho and the epithelial Ca2+ channel, TRPV5 [19,20].Recently, a new factor in the rapid regulation of Ca2+
homeostasis has been proposed, as fibroblast growth factor
23 (FGF23) was shown to promote renal Ca2+ reabsorption
through the TRPV5 channel in the distal tubule, and hereby
contributes to conserve Ca. In short time in vitro experi-
ments FGF23 increased the TRPV5 protein abundance and
the channel activity already after 45 minutes [21].
How and where the calciotropic hormones are setting the
set point for Ca2+ between bone and the ECF interphase is
less clear. Kurokawa assumed that PTH and calcitriol, in
concert, adjusted the set point for Ca2+ by regulating the
rate of the coupled bone resorption and formation [13].
However, the amount of calcium conserved by distal tu-
bules is minimal and the regulation of the rate of bone
turnover time consuming; as such these mechanisms can’t
be representative for the main mechanism involved in the
rapid minute-to-minute regulation of plasma Ca2+.
The existence of a labile pool of Ca2+ at the quiescent
surface of bone which is in dynamic equilibrium with
ECF has previously clearly been established by experi-
ments using incorporation of radiolabelled Ca in bone.
The magnitude of the rapid calcium exchange was esti-
mated to be many fold higher than the daily flux from
remodeling based bone turnover. This labile pool func-
tions as a short-term buffer, taking up or releasing cal-
cium to correct for changes in ECF [22]. Knowledge
concerning this process, as summarized in details by
Parfitt, has with some exceptions [2,9,10,12,22-25], dis-
appeared from the current texts [22,26].
Results from our lab have previously clearly shown that
neither PTH, calcitriol or CT were essential for the rapid
minute-to-minute regulation of plasma Ca2+ [9-12]. In
these studies the rapid recovery of plasma Ca2+ was exam-
ined after a brief induction of hypocalcemia with an EGTA
infusion in parathyroidectomized (PTX), thyroidecto-
mized (TX), thyroparathyroidectomized (TPTX) and cal-
citriol depleted rats and rats treated with different doses
of PTH, CT and calcitriol. The overall conclusion was that
none of these calciotropic hormones were prerequisite for
the rapid correction of plasma Ca2+ [9-12]. Our results
did, however as expected, clearly show a significant impact
of these calciotropic hormones on the long-term plasma
Ca2+ homeostasis, with the calciotropic hormones defin-
ing the plasma Ca2+ levels, by adjusting the set point for
plasma Ca2+ in a dose-related manner.
Furthermore, we have previously shown that the rapid
calcemic recovery, which occurs after a brief induction of
hypocalcemia does not result from suppression of CT
levels. Thus, the calcemic recovery curves were similar in
TPTX rats, normal and PTX rats and in rats given an ex-
ogenous salmon CT infusion. It was also clearly shown that
TPTX and selective TX resulted in similar increments of
plasma Ca2+. This indicated that the effect of removing
endogenous CT initially dominated over the effect of
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calcium efflux from bone to the extracellular fluid. The role
of PTH in the rapid, minute-to-minute plasma calcium
regulation was characterized by stable plasma Ca2+ for 2 h
after acute PTX [10]. It was also shown, that presence or
absence of CT had no influence on the rapid calcemic re-
covery. However, an immediate severe hypercalcemia, that
occurred after deprivation of CT, indicated that CT had an
acute effect on plasma Ca2+ levels, and as such that calcium
homeostasis was hormone-controlled, even on a minute-
to-minute basis [25]. Thus, our previous results clearly
pointed towards that the involvement of an exchangeable
calcium pool on the surface of bone was under hormonal
control and not just representing a physical - chemical
equilibrium between calcium crystals and extracellular
fluid, and in this way was keeping the extracellular calcium
concentration very stable [22].
The understanding of the regulation of the mineral
homeostasis and the function of the skeleton as a buffer
for Ca and P has regained new interest with the intro-
duction of the concept of the syndrome “Chronic Kid-
ney Disease - Mineral and Bone Disorder” (CKD-MBD)
by Moe et al. [27]. This concept emphasizes the import-
ant relationship between disturbed mineral homeostasis
in uremia and diminished ability of bone to accumulate
Ca and P, and it’s relation to the development of severe
complications, mainly vascular calcifications, that are so
characteristic for the uremic condition and which are
related to a substantial risk of increased morbidity and
mortality [28].
Hypocalcemia is an important complication in uremia.
Traditionally, hypocalcemia in uremia is explained by
the associated decreased renal biosynthesis of calcitriol,
P retention, decreased intestinal Ca absorption, and skel-
etal resistance to PTH, factors that all take time to re-
spond. However, a very rapid skeletal response to the
induction of acute kidney injury has recently been dem-
onstrated [29], where an acute kidney injury within one
hour resulted in a significant increase in the skeletal de-
rived phosphaturic hormone, FGF23 [29]. The timing of
this elevation of FGF23 might indicate the existence of a
kidney-bone axis, which is responding very rapidly to
kidney injury. Previously a parathyroid – bone axis has
been shown where PTX lead to a rapid decrease in
serum FGF23 and where exogeneous PTH within hours
lead to an increase in FGF23 [30], expanding the under-
standing of a close relation between bone and important
hormones in the calcium homeostasis.
Thus, the present investigation was conducted in order
to examine the performance of plasma Ca2+ in the very
early phase of acute uremia, as induced by total bilateral
nephrectomy and to study the effect of total absence of
kidneys on the rapid recovery of plasma Ca2+ from a
brief induction of acute hypocalcemia.Methods
Animals
The experimental studies were performed in accordance
with the National Institute for Health Guide for Care
and Use of Laboratory Animals and approved by the
Animal Experiments Inspectorate, the Ministry of Food,
Agriculture and Fisheries, Denmark (Reference: 2012-
DY-2934-00023). Adult male Wistar and DA rats weigh-
ing 250 g (Taconic A/S, Ejby, Denmark) were housed in
a temperature-controlled environment with a 12-hour
light/dark circle. The rats were given ad libitum access
to a standard diet (0.9% calcium, 0.7% phosphorus and
600 IU vitamin D per kg diet; Altromin, Spezialfutter
GmbH & Co., KG, Germany) and water. Rats were anes-
thetized with pentobarbital (50 microg/kg intraperitone-
ally; Nycomed-DAK, Copenhagen, Denmark). Additional
doses were administered when required in order to
maintain a steady level of anesthesia. Since DA and Wis-
tar rats had identical response of Ca2+ to nephrectomy
and recovery from acute hypocalcemia, the data are pre-
sented combined. The rats were not fasting before the
experiments.
Thyroparathyroidectomy (TPTX)
Acute TPTX was performed under stereomicroscope
using a microsurgical procedure with special care to
avoid trauma to the recurrent laryngeal nerve. The
model has previously been described from our lab [12].
Successful TPTX was confirmed by no detectable circu-
lating PTH and CT one hour after the operation [12].
Bilateral nephrectomy (NX)
NX was performed from the back by a one-step surgical
removal of both kidneys [31], as previously described [9].
The sham procedure consisted of incision in the skin only.
Induction of hypocalcemia by an EGTA infusion and
plasma measurements
Hypocalcemia was induced by an intravenous infusion
of EGTA (ethylene-bis(oxyethylenenitrilo)tetraacetic
acid; Sigma, USA), 40 mM, at a rate of 3.0 ml/h for
30 minutes (from time 60 to 90 minutes) through a
catheter inserted into the femoral vein. Plasma Ca2+ was
measured by a Calcium Selective Electrode (ABL505,
Radiometer, Copenhagen, Denmark). Plasma phosphate
was analyzed by Vitros 250 (Ortho-Clinical Diagnostics,
Raritan, NJ, USA).
Design
Rats were allocated to eight experimental models, and the
rapid regulation of plasma Ca2+ was examined in sham-
operated rats, NX rats, TPTX rats and NX-TPTX rats, as
presented in Table 1. The NX-TPTX model was introduced
in order to exclude the potential effect of accumulation of
Table 1 Rats were divided into four groups each
subdivided into receiving either NaCl or EGTA
Sham NX TPTX NX-TPTX
NaCl EGTA NaCl EGTA NaCl EGTA NaCl EGTA
n: 10 8 7 10 18 16 10 10
Number of rats (n) enrolled is specified.
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hypocalcemic actions on the acute uremia associated hypo-
calcemia [32,33]. The control groups were given infusion of
saline instead of EGTA. The rats were sham operated, NX,
TPTX or NX-TPTX at time 0, just after obtaining the time
0 blood samples. A short lasting infusion of EGTA or saline
was given via the femoral vein from time 60 to 90 minutes.
Samples for determination of plasma Ca2+ and phosphate
concentrations were obtained from a catheter in the fem-
oral artery at times 0, 60, 90, 100, 120, 140 min. After each
blood sample, the blood volume was replaced by infusion
of 0.4 ml NaCl. The hypocalcemic model is described in
more details from our lab [10].
Statistical analysis
The data are presented as mean ± SEM and compared
with Mann–Whitney test or t-test,. P < 0.05 is consid-
ered statistically significant.
Results
The effect of NX on plasma Ca2+ concentrations is illus-
trated in Figure 1. NX resulted in a rapid development
of significant hypocalcemia. Already at 60 minutes
plasma Ca2+ was significantly diminished in NX rats
compared to sham rats (p < 0.01). Then a further reduc-
tion of plasma Ca2+ took place. Plasma Ca2+ diminished
in NX rats from a basal value of 1.23 ± 0.02 to 1.06 ±
0.04 mmol/L at 140 min, p < 0.001, while sham rats,
given saline only, had a slight decrease in plasma Ca2+Figure 1 Rapid development of hypocalcemia in total
nephrectomized (NX) rats. Plasma Ca2+ concentrations in sham,
NX, TPTX, and NX-TPTX rats. Plasma Ca2+ in the NX rats declined
rapidly with development of significant hypocalcemia already
within 60 minutes, as compared to sham rats (p < 0.01). TPTX
resulted as expected in significant hypercalcemia (p < 0.05) within
60 minutes. The increase in plasma Ca2+ was significantly lower in
NX-TPTX rats, than in TPTX rats, (p <0.05).from 1.21 ± 0.01 to 1.17 ± 0.02 mmol/L (ns). TPTX re-
sulted as expected in hypercalcemia with a significant in-
crease in plasma Ca2+ from 1.29 ± 0.01 to 1.44 ±
0.02 mmol/L (p < 0.001). The increase in plasma Ca2+ was
significantly less in NX-TPTX rats, 1.29 ± 0.02 mmol/L,
than in TPTX rats, (p < 0.05) (Figure 1).
Further the minute-to-minute regulation of plasma Ca2+
was examined after the EGTA induced hypocalcemia. In
sham rats significant hypocalcemia with plasma Ca2+ falling
from 1.21 ± 0.01 to 0.81 ± 0.03 mmol/l (p < 0.001) devel-
oped within 30 minutes of EGTA infusion. Then subse-
quently a rapid and significant increase of plasma Ca2+
took place within 10 minutes after stopping the EGTA infu-
sion and with further recovery towards basal levels.
In order to examine any effect of the presence of kidneys
on the rapid minute-to-minute plasma Ca2+ regulation,
sham operated rats were compared to total bilateral NX
rats, as shown in Figure 2. The EGTA infused NX rats had
a significant lower nadir of hypocalcemia, as compared to
sham rats, 0.51 ± 0.02 vs. 0.80 ± 0.02 mmol/L, (p < 0.01)
and the concentration of plasma Ca2+ remained signifi-
cantly lower in the NX group during the recovery from
hypocalcemia, (p <0.01) at time 100, 120 and 140 minutes.
Thus in the presence of acute alterations in plasma Ca2+
concentration, NX rats had the ability to restore calcium
levels. The equilibrium is however now set by the new,
lower set-point, indicating an important role of the kidneys
in the very rapid regulation of the set-point for Ca2+ on
bone surfaces.
A possible direct or indirect effect of intact PTH, C-
terminal PTH or CT was further examined by comparing
the responses in TPTX and NX-TPTX rats, as shown in
Figure 3. By performing TPTX the effect of changes in in-
tact PTH, C-terminal PTH and CT is eliminated and in
this way provides the possibility for a pure examination of
the renal impact on the rapid plasma Ca2+ regulation. The
nadir of hypocalcemia in the EGTA infused NX-TPTXFigure 2 Impact of the kidney on recovery of plasma Ca2+ from
acute hypocalcemia. NX rats had a significant lower nadir of EGTA
induced hypocalcemia than EGTA infused sham rats (p < 0.01).
During the recovery from hypocalcemia the concentration of plasma
Ca2+ remained at all time points significantly lower in the NX group
compared to the sham group (p < 0.01).
Figure 3 Impact of the kidney on recovery of plasma Ca2+ from
acute hypocalcemia in thyroparathyroidectomized (TPTX) rats.
NX-TPTX rats had significantly lower nadir of EGTA induced hypocalcemia
than that of EGTA infused TPTX rats (p < 0.01). Plasma Ca2+ concentration
remained significantly lower in the NX-TPTX rats at all time points during
recovery from hypocalcemia, (p < 0.01).
Figure 4 Plasma-phosphate concentrations in NX, TPTX, NX-TPTX
and sham rats. Despite large deviations in plasma Ca2+ induced by
NX, TPTX, NX-TPTX and EGTA infusion plasma P levels remained stable
within the groups. The exception was in the NX-EGTA group, where a
significant increase of plasma phosphate (p < 0.01) developed late in
the experiment (please, see text).
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TPTX rats, 0.81 ± 0.03 vs. 1.00 ± 0.02 mmol/L, (p < 0.01).
Plasma Ca2+ concentrations were significantly lower in
the NX-TPTX rats, as compared to the TPTX rats during
the recovery from EGTA induced hypocalcemia, (p < 0.01)
at time 100, 120 and 140 minutes. Thus, also in this ex-
perimental situation the NX group had a downward shift
of the Ca recovery curve from acute hypocalcemia, once
again providing further support for the existence of a
rapid effect of NX on the set-point for Ca2+, which is inde-
pendent of PTH and CT, although it still is respecting the
degree of hypercalcemia, which developed post TPTX.
The basal normal plasma P concentrations were more
dispersed than basal Ca2+ values and differed from 1.74 ±
0.04 to 2.40 ± 0.6 mmol/L between the 8 groups of rats at
time 0 min, i.e. before any experimental procedure was
performed. After that plasma P remained stable within the
groups for the next 120 minutes, except in the NX-EGTA
group, where a significant increase of plasma P from 1.43
± 0.14 to 2.08 ± 0.13 mmol/L (p < 0.01) took place, as indi-
cated in Figure 4.
Discussion
The results of present study clearly show that plasma Ca2+
falls rapidly very early after induction of acute uremia, and
that plasma Ca2+ levels already 60 minutes after total
nephrectomy became significantly decreased and further
decreased for another 80 minutes. The mechanism for this
rapid decline of plasma Ca2+ is not known. Hypocalcemia,
as observed in patients with acute renal failure, was previ-
ously explained as being secondary to decreased synthesis
of calcitriol and development of hyperphosphatemia
[34,35]. The very early and rapid development of hypocal-
cemia, as observed in the present experimental model
cannot, however, be explained as being due to changes in
calcitriol or phosphate levels. Phosphate levels didn’t
change and the half-life of calcitriol is too long, 6 hours.In the uremic condition the metabolic clearance rate of
calcitriol is even lower, 57%, [36], even though these data
were obtained in a human study on patients on chronic
hemodialysis and not examined in acute uremia.
Our initial hypothesis was that this rapid development
of hypocalcemia in a model of total nephrectomy was
caused by accumulation of C-terminal PTH fragments
and/or of CT.
Mammalian intact PTH is a polypeptide consisting of
84 amino acids [37-39]. The N-terminal region of PTH
binds to the PTH1R [40], and is suggested to be the main
part of the hormone with the major biological activity. In-
creasing evidence, however, indicate the existence also of
a C-terminal PTH receptor (C-PTHR), that may have a
significant biological effects, which are related to the Ca2+
homeostasis [40]. Circulating C-terminal PTH fragments
are derived from the parathyroids and being a product of
hepatic proteolysis of intact PTH as well [41,42]. The large
C-PTH 7–84 fragment has been shown to have an effect
opposite to intact PTH, lowering plasma Ca2+ [43,44].
The C-terminal PTH fragments are mainly cleared
through the kidneys [45] as shown by our and other
groups [46,47] and could theoretically accumulate in the
acutely NX rats and thereby lead to the hypocalcemic re-
sponse. Previously we have shown a rapid hypocalcemic
effect of a large dose of PTH 7–84, which was seen already
within one hour [33]. Similarly, could the metabolism of
CT be diminished in NX rats, and thereby contribute to
the aggravation of hypocalcemia [32]. An impact of C-
terminal PTH fragments and/or CT on the rapid decline
of plasma Ca2+ in acute uremia, as previously hypothe-
sized from our lab, could however not be confirmed by
the results of the present investigation, as no influence of
PTH, C-terminal PTH and CT was found on plasma Ca2+
concentrations when comparing the models of TPTX
(without PTH and CT) and NX-TPTX rats (without PTH,
CT and kidneys). Thus, our present results interestingly
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involved in the rapid regulation of plasma Ca2+, and that this
very rapid regulation is not mediated by any of the classical
calciotropic hormones, PTH and 1,25(OH)2D or CT.
Christov et al. recently added another interesting aspect
to the possible existence of a rapid skeletal response to in-
duction of acute uremia, [29], even though plasma Ca2+
levels were not followed in the study. In models of acute
uremia they found an increase in FGF23 levels, which was
observed already at one hour after acute kidney injury
(AKI) [29]. This rapid elevation of FGF23 might further
add to the existence of a kidney-bone axis, which is
responding very rapidly to kidney injury. The P and Ca
regulating hormone, FGF23, is mainly secreted from oste-
ocytes. The osteocyte lineage, the lining cells, are covering
all quiescent bone surfaces, where the labile exchangeable
pool of calcium is supposed to take place [22]. As such re-
sults from the models of acute kidney injury [29] and the
present investigation on NX rats point toward the exist-
ence of a rapid signal being exchanged between kidneys
and osteocytes.
In the present study a decreased plasma Ca2+ level was
observed in NX-TPTX rats compared to TPTX rats, indi-
cating that the Ca2+ lowering effect of NX was independent
of a PTH signal. Similarly, in the study of Christov et al.
[29] elevation of FGF23 levels were found when AKI was
induced in wild type mice, mice with osteocyte specific
PTHR ablation or the deletion of PTH, indicating that the
increase in FGF23 was not dependent on PTH signaling.
Taken together, our results on NX rats and the results from
AKI models suggest that PTH signaling is not necessary for
the early skeletal response to acute uremia.
TPTX rats developed significant hypercalcemia, which
is in line with our previous results [12]. This observation
was originally made years ago by Copp, and lead to the
discovery of CT [48]. The hypercalcemic response is
caused by the eliminated CT tonus on bone, which appar-
ently overrules the effect of PTX on bone [12]. The hyper-
calcemic effect of TPTX was diminished in the NX-TPTX
group and NX-TPTX rats had lower plasma Ca2+ concen-
trations throughout the study, once again indicating that
presence of kidneys influences the plasma Ca2+ concentra-
tion on a minute-to-minute basis.
EGTA is a specific calcium chelator that induces hypo-
calcemia by binding calcium in a stable physiological inert
complex. The stability of the Ca2+-EGTA complex has
previously been carefully examined by our group and it
was clearly shown that the rapid recovery of plasma Ca2+
was not due to dissociation of calcium from the complex,
not due to induction of a decreased plasma P and was not
a product of alterations in plasma pH [10]. Thus EGTA
binds Ca in blood with no subsequent dissociation of Ca.
Whether the elimination of the renal clearance of EGTA
in NX rats contributes to an accumulation of EGTAcannot completely be ruled out. Such an accumulation
could theoretically have lead to an increased net amount
of active EGTA and as such to an augmented Ca chelation
and thereby to a more profound hypocalcemic response.
In this respect it is important to notice that hypocalcemia
also developed in NX rats that were not infused with
EGTA. Furthermore, hypocalcemia in NX rats developed
already at 60 minutes, which means before any intraven-
ous infusion of EGTA.
Another question is whether plasma P levels are affected
by the acute NX and thereby could have an effect on plasma
Ca2+ regulation. Surprisingly, despite development of hypo-
calcemia NX rats had stable plasma P for 60 minutes post
NX, clearly demonstrating that acute hypocalcemia was not
balanced by acute recipocal hyperphosphatemia. Further-
more, plasma P remained stable independent of EGTA in-
duced changes in plasma Ca2+ and independent of the
presence of PTH. This dissociation between plasma Ca2+
and plasma P levels is in accordance with results on diurnal
variations of the two ions [5].
Surprisingly, the basal normal plasma P concentrations
were considerably more dispersed than the basal plasma
Ca2+ values. At present this is not explained. Plasma P
remained stable within the groups, except in the NX-EGTA
group, where a significant increase of plasma P (p < 0.01)
took place. Potentially this could be explained by a stimula-
tory effect of the EGTA induced hypocalcemia on the PTH
secretion [49] in a situation where the increased PTH would
result in release of P from the skeleton, but could not induce
phosphaturia as the rats were NX.
The results of the current investigation clearly dem-
onstrated that the kidneys affect the rapid changes in
plasma Ca2+. The demonstration, that the induction of
and recovery from hypocalcemia is significantly lower in
NX rats, independently of PTH, C-terminal PTH and
CT in the circulation, might indirectly indicate that
presence of kidney is of significant importance for the
setting the set-point for Ca2+ on bone surfaces. We,
therefore, suggest that there might exist an as yet un-
known factor or mechanism, which is involved in the
very rapid signaling between kidney and bone, and
which is affecting the minute-to-minute regulation of
plasma Ca2+. We suggest that this factor acts rapidly as
a hormone or a mechanism with a hormone-like effect
on bone, and thereby sets the ‘set-point’ for plasma Ca2+
regulation on bone.
Conclusion
In conclusion, our results clearly demonstrate that
plasma Ca2+ concentrations on a minute-to-minute
basis are influenced by the presence of kidneys. This in-
dicates that the kidneys are of significant importance for
the ‘set-point’ of plasma Ca2+ on bone independent of
PTH and calcitonin. Our results point toward the
Nordholm et al. BMC Nephrology  (2015) 16:29 Page 7 of 8existence of an as yet unknown factor/mechanism,
which mediates signals between kidney and bone, and
which is involved in the very rapid regulation of plasma
Ca2+.
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